Project

Sanofi PMR EFC15160

Automatically Closed ยท 2019 until 2021

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2019
End Date
2021
Financing
Industry
Brief description/objective

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and
safety of sarilumab in patients with polymyalgia rheumatica